Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesDiseases and Disorders of the Female Reproductive SystemDRG 734-pelvic-evisceration-radical-hysterectomy-and-radical-vulvectomy-with-cc-mcc
    Ask Trek AI about this page

    Pelvic Evisceration, Radical Hysterectomy and Radical Vulvectomy with CC/MCC: Inpatient Reimbursement Overview

    DRG 734 encompasses pelvic evisceration, radical hysterectomy, and radical vulvectomy when a Complication or Comorbidity or Major Complication or Comorbidity is present; it captures high-acuity gynecologic pelvic surgeries. This Diagnosis-Related Group matters because documented case complexity and complications directly affect inpatient Medicare reimbursement and resource planning.

    Customize your policy alerts

    Sign up for drg 734 policy alerts

    Get alerted when payer policies referencing 734 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 734 Overview

    DRG 734 covers extensive pelvic operative procedures including pelvic evisceration, radical hysterectomy, and radical vulvectomy performed with a documented Complication or Comorbidity or Major Complication or Comorbidity. These are high-acuity gynecologic oncologic and pelvic surgery cases with significant resource use, often involving extensive resection and reconstruction. This Diagnosis-Related Group matters for Medicare payment because case complexity and documented complications or comorbidities influence inpatient reimbursement and hospital resource allocation. Accurate clinical documentation and coding determine assignment to the appropriate Diagnosis-Related Group and associated payment weight.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Perioperative morbidity reduction trials: randomized or pragmatic studies evaluating protocols to reduce intraoperative blood loss, transfusion requirements, and immediate postoperative complications in patients undergoing pelvic exenteration, radical hysterectomy, or radical vulvectomy for advanced gynecologic malignancies. These studies enroll high-risk inpatients (often with prior radiation, large pelvic tumors, or extensive surgical resections) and test multimodal bundles such as enhanced surgical hemostasis techniques, targeted perioperative hemodynamic management, and standardized ICU/ward pathways. Results are directly relevant to providers and payers because reducing complications and length of stay can lower intensive resource utilization and improve DRG cost predictability.
    • Comparative effectiveness studies of surgical approach and reconstruction options: observational cohorts or pragmatic trials comparing different operative strategies (eg, extent of resection margins, organ-sparing variations when oncologically appropriate) and types of pelvic reconstruction or wound management (flap reconstructions, negative-pressure wound therapy) in patients undergoing these radical pelvic procedures. These studies focus on functional outcomes, wound healing, reoperation rates, and long-term quality of life among survivors, often stratified by tumor type, prior radiation exposure, and comorbidity burden. Findings inform surgical decision-making, resource allocation, and post-acute care planning for providers and payers by identifying approaches that balance oncologic control with lower complication-related costs.
    • Post-discharge outcomes and survivorship studies: longitudinal studies and registries tracking readmissions, late surgical complications, rehabilitation needs, and patient-reported outcomes (pain, sexual and urinary/intestinal function, and return to baseline activities) after discharge from the index hospitalization for pelvic evisceration or radical gynecologic surgery. These studies typically follow diverse inpatient cohorts through the first year after surgery to quantify drivers of readmission, outpatient service use, and long-term home health or skilled nursing needs. For payers and health systems, understanding these downstream costs and functional trajectories is essential for bundled payment planning, predicting post-discharge resource use tied to the DRG, and designing targeted interventions to reduce costly readmissions.

    Related Codes

    735-PELVIC-EVISCERATION-RADICAL-HYSTERECTOMY-AND-RADICAL-VULVECTOMY-WITHOUT-CC-MCC

    Pelvic Evisceration, Radical Hysterectomy and Radical Vulvectomy: Inpatient Reimbursement Overview

    736-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITH-MCC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy with MCC: Inpatient Reimbursement Overview

    737-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITH-CC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy with CC: Inpatient Reimbursement Overview

    738-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy without CC/MCC: Inpatient Reimbursement Overview

    739-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITH-MCC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with MCC: Inpatient Reimbursement Overview

    740-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITH-CC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with CC: Inpatient Reimbursement Overview

    741-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy without CC/MCC: Inpatient Reimbursement Overview

    742-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-MALIGNANCY-WITH-CC-MCC

    Uterine and Adnexa Procedures for Non-Malignancy with CC/MCC: Inpatient Reimbursement Overview

    743-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Non-Malignancy without CC/MCC: Inpatient Reimbursement Overview

    744-D-C-CONIZATION-LAPAROSCOPY-AND-TUBAL-INTERRUPTION-WITH-CC-MCC

    D&C, Conization, Laparoscopy and Tubal Interruption with CC/MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 24

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.